We used quantitative PCR to follow DUX4 messenger RNA (mRNA) transcripts during myogenic differentiation to determine the gene expression profile of DUX4 in cells from FSHD-affected and unaffected individuals. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.